Randi M L, Casonato A, Fabris F, Vio C, Girolami A
University of Padua Medical School, Institute of Medical Semeiotics, Italy.
Acta Haematol. 1987;78(1):41-4. doi: 10.1159/000205834.
We performed a retrospective study on 21 patients, aged 70 years or more, affected by polycythemia vera (PV) or essential thrombocythemia (ET). As controls, we evaluated 10 younger ET patients. The results indicate that in older ET subjects there was a lower incidence of hemorrhagic and thrombotic complications than in younger patients and PV patients. However, platelet number and platelet function tests were similar in all the patients studied. We suppose that an increase in hematocrit as seen in PV is much more dangerous as compared to an isolated increase in platelet count, and that thrombocytosis alone in old age can be an isolated expression of a natural involution of blood marrow similar to myelofibrosis.
我们对21名年龄在70岁及以上、患有真性红细胞增多症(PV)或原发性血小板增多症(ET)的患者进行了一项回顾性研究。作为对照,我们评估了10名年龄较小的ET患者。结果表明,与年轻患者和PV患者相比,老年ET患者出血和血栓并发症的发生率较低。然而,在所有研究患者中,血小板数量和血小板功能测试结果相似。我们推测,与单纯血小板计数增加相比,PV中所见的血细胞比容增加要危险得多,而且老年时单纯的血小板增多可能是骨髓自然退化的一种孤立表现,类似于骨髓纤维化。